forms of S6K, and to HSP90 (loading control). e, MEFs stably expressing EGFP-LC3 were cultured in complete or amino acid-free (starvation) medium for 2 h, fixed, permeabilized, and subjected to immunofluorescence analysis with antibodies to FKBP38 and to cytochrome c.
They were also monitored directly for EGFP-LC3 fluorescence. Bars (a, b, e), 10 µm.
Supplementary Figure S4 FKBP38 translocation from mitochondria to the ER is not blocked by lysosomal inhibition. a, MEFs stably expressing EGFP-Parkin were incubated in
the absence or presence of CCCP (30 µM) alone or together with Bafilomycin A1 (100 nM) for 24 h, fixed, permeabilized, and subjected to immunofluorescence analysis with antibodies to FKBP38 and to cytochrome c. They were also monitored directly for EGFP-Parkin fluorescence.
Higher magnification views of the boxed areas are shown in the rightmost panels. b, MEFs stably expressing FLAG-Parkin and EGFP-VAP-A were incubated as in a, fixed, permeabilized, and subjected to immunofluorescence analysis with antibodies to FKBP38 and to FLAG (M2).
They were also monitored directly for EGFP-VAP-A fluorescence. Bars (a, b), 10 µm. 
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